LAVIV is indicated for improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults.

LAVIV® (azficel-T) is an autologous cellular product indicated for improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. The safety and efficacy of LAVIV for...

2011年8月1日 · In June, after a nearly ten-year review, the US Food and Drug Administration (FDA) approved laViv (azficel-T), a first-in-class personalized cell therapy for eliminating fine wrinkles or...

2011年6月22日 · The patented technology behind laViv is an advanced process that extracts and multiplies a specific kind of a person's own skin cells (fibroblasts) to create laViv, which is then injected into...

Azficel-T, sold under the brand name Laviv, is a cell therapy product for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. [1][2][3] It consists of fibroblasts harvested from the patient's own skin. [2] It was approved for medical use in the United States in June 2011. [2]

laViv自体成纤维细胞注射是美国Fibrocell公司开发的自体成纤维细胞移植美容技术，2011年6月22日获美国食品药品管理局 (FDA)批准用于改善成人中重度鼻唇沟皱纹。

2010年12月20日 · LaViv FDA Approval History FDA Approved: Yes (First approved June 21, 2011) Brand name: LaViv Generic name: azficel-T Company: Fibrocell Science, Inc. Treatment for: Wrinkles Azficel-T is an autologous cellular product indicated for improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. Development timeline for ...

2011年6月22日，Fibrocell Science公司宣布美国食品药品管理局(FDA)已批准laViv (azficel-T)用于改善成人中重度鼻唇沟皱纹(微笑线)的美观程度。 laViv是一种个体化美学细胞疗法，其专利技术是提取患者本人生成胶原的皮肤细胞——成纤维细胞并进行增殖。

laVív是被FDA第一个和唯一的个性化的审美细胞疗法 [personalized aesthetic cell therapy]为在成年中改善中度至严重鼻唇沟皱纹 [nasolabial fold wrinkles] (微笑线)的外观。 在临床试验中。 laVív大部分不良事件是轻至中度强度和在1周内解决注射部位反应被..

laVív是被FDA第一个和唯一的个性化的审美细胞疗法 [personalized aesthetic cell therapy]为在成年中改善中度至严重鼻唇沟皱纹 [nasolabial fold wrinkles] (微笑线)的外观。 在临床试验中。 laVív大部分不良事件是轻至中度强度和在1周内解决注射部位反应被很好耐受。